210_110thumbnailrev.jpg Highlights and Insights from the Metabolic and Endocrine Disease Summit Earn up to 2.0 AMA PRA Category 1 Credits™ 0.4 contact hours of pharmacotherapy content 1.3 contact hours 681264_thumb_01.png Case Challenges in the Use of Insulin in T2DM 0.75 AMA PRA Category 1 Credit™ 681264_thumb_01.png Management of T2DM: The Role of Insulin 0.75 AMA PRA Category 1 Credit™ 681264_thumb_01.png Team-Based Care for Patients with Type 2 Diabetes 1 AMA PRA Category 1 Credit™1 CDR continuing professional education unit 681264_thumb_01.png Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated LDL-C 1 AMA PRA Category 1 Credit™1 ACPE contact hour1 ANCC contact hour1 CDR continuing professional education unit 681264_thumb_01.png Evaluating and Initiating Opioid ER/LA Analgesic Therapy 0.5 AMA PRA Category 1 Credit™ 0.5 ANCC contact hour onycho_supplement_cover_2.jpg Onychomycosis: Diagnosis, Treatment, and Prevention Strategies Expired SCMSOnychomycosis_Supplement_cover_new.png Managing Onychomycosis: New and Emerging Treatments and Recurrence Prevention Strategies Expired
210_110thumbnailrev.jpg Highlights and Insights from the Metabolic and Endocrine Disease Summit Earn up to 2.0 AMA PRA Category 1 Credits™ 0.4 contact hours of pharmacotherapy content 1.3 contact hours
681264_thumb_01.png Team-Based Care for Patients with Type 2 Diabetes 1 AMA PRA Category 1 Credit™1 CDR continuing professional education unit
681264_thumb_01.png Navigating the Challenges of Prescribing PCSK9 Inhibitors in Patients with Persistent Elevated LDL-C 1 AMA PRA Category 1 Credit™1 ACPE contact hour1 ANCC contact hour1 CDR continuing professional education unit
681264_thumb_01.png Evaluating and Initiating Opioid ER/LA Analgesic Therapy 0.5 AMA PRA Category 1 Credit™ 0.5 ANCC contact hour
SCMSOnychomycosis_Supplement_cover_new.png Managing Onychomycosis: New and Emerging Treatments and Recurrence Prevention Strategies Expired
